These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 9022037)

  • 21. Identification and characterization of T helper epitopes in the nucleoprotein of influenza A virus.
    Gao XM; Liew FY; Tite JP
    J Immunol; 1989 Nov; 143(9):3007-14. PubMed ID: 2478631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Priming of influenza virus-specific cytotoxic T lymphocytes vivo by short synthetic peptides.
    Gao XM; Zheng B; Liew FY; Brett S; Tite J
    J Immunol; 1991 Nov; 147(10):3268-73. PubMed ID: 1682377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Formaldehyde inactivation of measles virus abolishes CD46-dependent presentation of nucleoprotein to murine class I-restricted CTLs but not to class II-restricted helper T cells.
    Cardoso AI; Beauverger P; Gerlier D; Wild TF; Rabourdin-Combe C
    Virology; 1995 Sep; 212(1):255-8. PubMed ID: 7676641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The selective proteasome inhibitors lactacystin and epoxomicin can be used to either up- or down-regulate antigen presentation at nontoxic doses.
    Schwarz K; de Giuli R; Schmidtke G; Kostka S; van den Broek M; Kim KB; Crews CM; Kraft R; Groettrup M
    J Immunol; 2000 Jun; 164(12):6147-57. PubMed ID: 10843664
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-viral protection and prevention of lymphocytic choriomeningitis or of the local footpad swelling reaction in mice by immunization with vaccinia-recombinant virus expressing LCMV-WE nucleoprotein or glycoprotein.
    Hany M; Oehen S; Schulz M; Hengartner H; Mackett M; Bishop DH; Overton H; Zinkernagel RM
    Eur J Immunol; 1989 Mar; 19(3):417-24. PubMed ID: 2468501
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recognition by major histocompatibility complex class I-restricted cytolytic T lymphocytes of cells expressing vaccinia-encoded viral and class I proteins.
    Andrew ME; Coupar BE; Boyle DB; Blanden RV
    Eur J Immunol; 1987 Oct; 17(10):1515-8. PubMed ID: 3500060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nonimmunogenic tumor cells may efficiently restimulate tumor antigen-specific cytotoxic T cells.
    Kündig TM; Bachmann MF; Lefrancois L; Puddington L; Hengartner H; Zinkernagel RM
    J Immunol; 1993 May; 150(10):4450-6. PubMed ID: 8097755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Major histocompatibility complex class I-restricted presentation of influenza virus nucleoprotein peptide by B lymphoma cells harboring an antibody gene antigenized with the virus peptide.
    Billetta R; Filaci G; Zanetti M
    Eur J Immunol; 1995 Mar; 25(3):776-83. PubMed ID: 7705408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential roles of protein oxidation and the immunoproteasome in MHC class I antigen presentation: the 'PrOxI' hypothesis.
    Teoh CY; Davies KJ
    Arch Biochem Biophys; 2004 Mar; 423(1):88-96. PubMed ID: 14871471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Presentation of a new H-2D(k)-restricted epitope in the Tax protein of human T-lymphotropic virus type I is enhanced by the proteasome inhibitor lactacystin.
    Lomas M; Hanon E; Tanaka Y; Bangham CRM; Gould KG
    J Gen Virol; 2002 Mar; 83(Pt 3):641-650. PubMed ID: 11842259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sequential cleavage by metallopeptidases and proteasomes is involved in processing HIV-1 ENV epitope for endogenous MHC class I antigen presentation.
    López D; Gil-Torregrosa BC; Bergmann C; Del Val M
    J Immunol; 2000 May; 164(10):5070-7. PubMed ID: 10799863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The requirement for proteasome activity class I major histocompatibility complex antigen presentation is dictated by the length of preprocessed antigen.
    Yang B; Hahn YS; Hahn CS; Braciale TJ
    J Exp Med; 1996 Apr; 183(4):1545-52. PubMed ID: 8666912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The proteasome inhibitor lactacystin prevents the generation of an endoplasmic reticulum leader-derived T cell epitope.
    Gallimore A; Schwarz K; van den Broek M; Hengartner H; Groettrup M
    Mol Immunol; 1998 Jul; 35(10):581-91. PubMed ID: 9823757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Presentation by a major histocompatibility complex class I molecule of nucleoprotein peptide expressed in two different genes of an influenza virus transfectant.
    Isobe H; Moran T; Li S; Young A; Nathenson S; Palese P; Bona C
    J Exp Med; 1995 Jan; 181(1):203-13. PubMed ID: 7528768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IFN-gamma exposes a cryptic cytotoxic T lymphocyte epitope in HIV-1 reverse transcriptase.
    Sewell AK; Price DA; Teisserenc H; Booth BL; Gileadi U; Flavin FM; Trowsdale J; Phillips RE; Cerundolo V
    J Immunol; 1999 Jun; 162(12):7075-9. PubMed ID: 10358150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Viruses use stealth technology to escape from the host immune system.
    Wiertz EJ; Mukherjee S; Ploegh HL
    Mol Med Today; 1997 Mar; 3(3):116-23. PubMed ID: 9095486
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of proteasomal activity required for the generation of a cytotoxic T lymphocyte-defined peptide derived from the tumor antigen MAGE-3.
    Valmori D; Gileadi U; Servis C; Dunbar PR; Cerottini JC; Romero P; Cerundolo V; Lévy F
    J Exp Med; 1999 Mar; 189(6):895-906. PubMed ID: 10075973
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generation of an immunodominant CTL epitope is affected by proteasome subunit composition and stability of the antigenic protein.
    Gileadi U; Moins-Teisserenc HT; Correa I; Booth BL; Dunbar PR; Sewell AK; Trowsdale J; Phillips RE; Cerundolo V
    J Immunol; 1999 Dec; 163(11):6045-52. PubMed ID: 10570292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intracellular localization of proteasomal degradation of a viral antigen.
    Antón LC; Schubert U; Bacík I; Princiotta MF; Wearsch PA; Gibbs J; Day PM; Realini C; Rechsteiner MC; Bennink JR; Yewdell JW
    J Cell Biol; 1999 Jul; 146(1):113-24. PubMed ID: 10402464
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proteasome inhibitors block the entry of liposome-encapsulated antigens into the classical MHC class I pathway.
    Rothwell SW; Wassef NM; Alving CR; Rao M
    Immunol Lett; 2000 Oct; 74(2):141-52. PubMed ID: 10996390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.